Frequency Therapeutics Inc.

Lexeo Therapeutics Inc. became the 20th biopharma to launch an initial public offering in the US on 2 November when it sold 9.09 million shares at $11 each to gross $100m in its late-night public mar

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sangamo Partners In Neurology With Lill

Since it has become difficult for many biopharmaceutical companies to raise money during the past year and a half, several firms have been forced to cut costs to make remaining cash balances last long

Astellas Pharma, Inc. will book an impairment loss totalling JPY58.3bn ($437m) in the fourth quarter of its fiscal year just ended on 31 March, in a decision set to dent its previously forecast profi